Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126078121 | 12607812 | 1 | I | 2012 | 20160722 | 20160729 | 20160729 | EXP | US-ASTRAZENECA-2016SE80366 | ASTRAZENECA | 68.00 | YR | F | Y | 68.00000 | KG | 20160729 | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126078121 | 12607812 | 1 | PS | CRESTOR | ROSUVASTATIN CALCIUM | 1 | Oral | 21366 | TABLET | ||||||||||
126078121 | 12607812 | 2 | C | LEVOTHYROXINE. | LEVOTHYROXINE | 1 | Oral | 0 | |||||||||||
126078121 | 12607812 | 3 | C | LOSARTAN. | LOSARTAN | 1 | Oral | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126078121 | 12607812 | 1 | Blood cholesterol increased |
126078121 | 12607812 | 2 | Hypothyroidism |
126078121 | 12607812 | 3 | Blood pressure abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126078121 | 12607812 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126078121 | 12607812 | Body height decreased | |
126078121 | 12607812 | Coronary artery occlusion | |
126078121 | 12607812 | Intentional product misuse | |
126078121 | 12607812 | Low density lipoprotein increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126078121 | 12607812 | 1 | 2012 | 0 |